首页> 外文会议>Annual Conference of Japanese Society for Medical and Biological Engineering;Annual International Conference of the IEEE Engineering in Medicine and Biology Society >Patient in control in clinical trials - European initiatives for improving patient empowerment in clinical trials through technical implementation of legal norms
【24h】

Patient in control in clinical trials - European initiatives for improving patient empowerment in clinical trials through technical implementation of legal norms

机译:在临床试验中控制患者-通过法律规范的技术实施来提高临床试验中患者的能力的欧洲倡议

获取原文
获取原文并翻译 | 示例

摘要

Patient empowerment is acclaimed as one of the major trends in the health care area bringing forward new conceptions how to involve patients in clinical research in a more (inter)active way. Patients and clinicians could benefit from more flexible consent-management and improved communication processes. This is where technology comes as an asset - the novel technological approaches promise to give more control to the patient, lessen the burdens on the researchers and all that in compliance with the legal and ethical requirements (e.g. data protection). The views of the European projects EURECA and p-medicine serve as examples for European approaches to patient empowerment.
机译:赋予患者权力是卫生保健领域的主要趋势之一,它提出了新的观念,即如何使患者以更加(互动)的方式参与临床研究。患者和临床医生可以从更灵活的同意书管理和改进的沟通流程中受益。这就是技术成为资产的地方-新颖的技术方法有望为患者提供更多控制权,减轻研究人员的负担以及所有符合法律和道德要求(例如数据保护)的负担。欧洲项目EURECA和p-medical的观点可作为欧洲增强患者权能方法的范例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号